Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Morton

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Brachytherapy|December 15, 2017
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapyAlexandru Nicolae, Jure Murgic, Ivan Kruljac, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2011
Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancerHarvey Quon, Patrick C F Cheung, D Andrew Loblaw, et al.
MDM Policy & Practice|October 6, 2018
Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision AnalysisChristopher J D Wallis, Gerard Morton, Angela Jerath, et al.
Practical Radiation Oncology|June 19, 2022
A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 PatientsMark T Corkum, Gerard Morton, D Andrew Loblaw, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 25, 2016
Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment programDavid Guy, Gabriella Ghanem, Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2011
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?Gerard Morton, Andrew Loblaw, Patrick Cheung, et al.
Advances in Radiation Oncology|November 2, 2019
A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate CancerLara Hathout, Omar Mahmoud, Yaqun Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicityHarvey Quon, Patrick C F Cheung, D Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 28, 2020
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trialMark Corkum, Andrew Loblaw, Yaser Hasan, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Brachytherapy|December 15, 2017
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapyAlexandru Nicolae, Jure Murgic, Ivan Kruljac, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2011
Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancerHarvey Quon, Patrick C F Cheung, D Andrew Loblaw, et al.
MDM Policy & Practice|October 6, 2018
Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision AnalysisChristopher J D Wallis, Gerard Morton, Angela Jerath, et al.
Practical Radiation Oncology|June 19, 2022
A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 PatientsMark T Corkum, Gerard Morton, D Andrew Loblaw, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 25, 2016
Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment programDavid Guy, Gabriella Ghanem, Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2011
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?Gerard Morton, Andrew Loblaw, Patrick Cheung, et al.
Advances in Radiation Oncology|November 2, 2019
A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate CancerLara Hathout, Omar Mahmoud, Yaqun Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicityHarvey Quon, Patrick C F Cheung, D Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 28, 2020
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trialMark Corkum, Andrew Loblaw, Yaser Hasan, et al.
Pageof 13